Kazia Therapeutics Statistics

Total Valuation

KZIA has a market cap or net worth of $27.61 million. The enterprise value is $25.02 million.

Market Cap	27.61M
Enterprise Value	25.02M

Important Dates

The next estimated earnings date is Friday, December 26, 2025, before market open.

Earnings Date	Dec 26, 2025
Ex-Dividend Date	n/a

Share Statistics

KZIA has 1.83 million shares outstanding. The number of shares has increased by 107.81% in one year.

Current Share Class	n/a
Shares Outstanding	1.83M
Shares Change (YoY)	+107.81%
Shares Change (QoQ)	+57.76%
Owned by Insiders (%)	8.12%
Owned by Institutions (%)	11.67%
Float	1.69M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	13.75
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	20.87
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.35

Current Ratio	0.35
Quick Ratio	0.32
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-64.28%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	177.89%
Revenue Per Employee	$199,851
Profits Per Employee	-$2.26M
Employee Count	6
Asset Turnover	0.13
Inventory Turnover	n/a

Taxes

Income Tax	-1.14M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -33.48% in the last 52 weeks. The beta is 1.68, so KZIA's price volatility has been higher than the market average.

Beta (5Y)	1.68
52-Week Price Change	-33.48%
50-Day Moving Average	7.93
200-Day Moving Average	6.60
Relative Strength Index (RSI)	71.62
Average Volume (20 Days)	1,928,655

Short Selling Information

Short Interest	12,176
Short Previous Month	19,336
Short % of Shares Out	0.73%
Short % of Float	n/a
Short Ratio (days to cover)	0.18

Income Statement

In the last 12 months, KZIA had revenue of $1.20 million and -$13.57 million in losses. Loss per share was -$12.38.

Revenue	1.20M
Gross Profit	1.20M
Operating Income	-9.32M
Pretax Income	-14.72M
Net Income	-13.57M
EBITDA	-8.71M
EBIT	-9.32M
Loss Per Share	-$12.38

Full Income Statement

Balance Sheet

The company has $2.85 million in cash and $259,621 in debt, giving a net cash position of $2.59 million or $1.41 per share.

Cash & Cash Equivalents	2.85M
Total Debt	259,621
Net Cash	2.59M
Net Cash Per Share	$1.41
Equity (Book Value)	-5.44M
Book Value Per Share	-3.36
Working Capital	-5.98M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-8.71M
Capital Expenditures	n/a
Free Cash Flow	-8.82M
FCF Per Share	-$4.81

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-777.31%
Pretax Margin	-1,227.34%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KZIA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-107.81%
Shareholder Yield	-107.81%
Earnings Yield	-49.16%
FCF Yield	-31.95%

Dividend Details

Analyst Forecast

The average price target for KZIA is $16.00, which is 6.31% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$16.00
Price Target Difference	6.31%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	148.21%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on April 17, 2025. It was a reverse split with a ratio of 1:5.

Last Split Date	Apr 17, 2025
Split Type	Reverse
Split Ratio	1:5

Scores

KZIA has an Altman Z-Score of -39.74 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-39.74
Piotroski F-Score	3